Filing Details

Accession Number:
0000899866-14-000045
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-10 18:46:51
Reporting Period:
2014-02-06
Filing Date:
2014-02-10
Accepted Time:
2014-02-10 18:46:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899866 Alexion Pharmaceuticals Inc ALXN Pharmaceutical Preparations (2834) 133648318
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1564621 B John Moriarty Alexion Pharmaceuticals
352 Knotter Drive
Cheshire CT 06410
Svp & General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $.0001 Per Share Acquisiton 2014-02-06 6,068 $0.00 23,268 No 4 A Direct
Common Stock, Par Value $.0001 Per Share Disposition 2014-02-07 1,020 $155.55 22,248 No 4 S Direct
Common Stock, Par Value $.0001 Per Share Disposition 2014-02-07 16 $158.56 22,232 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. On February 6, 2013, the reporting person was granted a performance award representing the right to receive 8,290 shares of common stock upon achievement of certain performance targets and on February 6, 2014 the Compensation Committee certified achievement of the performance targets. 1/3 of such shares vested on February 6, 2014 and 1/3 vest on each subsequent anniversary.
  2. This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units.